Last reviewed · How we verify
Live Francisella Tularensis Vaccine — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Live Francisella Tularensis Vaccine (Live Francisella Tularensis Vaccine) — U.S. Army Medical Research and Development Command.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Live Francisella Tularensis Vaccine TARGET | Live Francisella Tularensis Vaccine | U.S. Army Medical Research and Development Command | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Live Francisella Tularensis Vaccine CI watch — RSS
- Live Francisella Tularensis Vaccine CI watch — Atom
- Live Francisella Tularensis Vaccine CI watch — JSON
- Live Francisella Tularensis Vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Live Francisella Tularensis Vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/live-francisella-tularensis-vaccine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab